70
Participants
Start Date
October 19, 2015
Primary Completion Date
January 31, 2021
Study Completion Date
January 31, 2021
Palbociclib
Given orally (PO)
Tamoxifen
Given orally (PO)
Fulvestrant
Given by intramuscular (IM) injection.
Georgetown University, Washington D.C.
Johns Hopkins University, Baltimore
Vanderbilt University, Nashville
Indiana University, Indianapolis
University of Michigan, Ann Arbor
University of Chicago, Chicago
Baylor College of Medicine, Houston
University of California, San Francisco, San Francisco
Dana-Farber Cancer Institute, Boston
Translational Breast Cancer Research Consortium
OTHER
Dana-Farber Cancer Institute
OTHER
University of California, San Francisco
OTHER